Register Here

2018 Associate Sponsors


2018 Exhibitors


2018 Supporting Partners

Myeloma Crowd
Patient Empowerment Network
Patient Worthy

2018 Media Partners

BioPharma Dive
BioPharm Insight
Life Science Leader
Rebar Interactive
Technology Networks

2017 Speaker Presentations

Day 1

A Cancer Survivor Story: Jamie Goldfarb’s Journey

Jamie Goldfarb
Patient Survivor and Advocate

How The Role of The Patient Advocacy Function within Industry/Pharma Evolved and What it Should Be

Kathy Gram
VP, Patient Advocacy, Snow Companies

Amy Fisher, MS, CGC
Patient Advocacy Lead, Spark Therapeutics

Jodie Gillon
Senior Director, Advocacy & Professional Society Affairs, Achillion Pharmaceuticals

Sharon Hesterlee, PhD
Director of Patient Relations and Public Affairs, Bamboo Pfizer

Large Pharma Case Studies on the Progress of Patient Involvement

Victoria DiBiaso, MPH
Associate VP, Global Head Clinical Operations Strategy & Collaboration, Sanofi
Sanofi’s model: Integrating Patient Perspectives Across Research & Development

Paulo Moreira
VP, Global Clinical Operations, Head of External Innovation, EMD Serono
Case Study

Michelle Vichnin, MD
Executive Director, Oncology, Office of the Chief Medical Officer, Merck
Case Study from Merck

The Science of Patient Input

Maureen Japha, JD
Director, Regulatory Policy, FasterCures

Value Framework Developments: Patient Involvement and Progress of Models

Marc Boutin, JD
Chief Executive Officer, National Health Council

Maureen Japha, JD
Director, Regulatory Policy, FasterCures

Deb Maskens
Vice Chair, International Kidney Cancer Coalition

Dana Wollins
Senior Director of Health Policy, American Society of Clinical Oncology (ASCO)

The Medicine Information Exchange – What Patients and other Stakeholders Need to Say to One Another

Marilyn Metcalf
Head, Centre of Innovation, Global Clinical Safety and Pharmacovigilance, Global Medical, GlaxoSmithKline

Janet Freeman-Daily
Lung Cancer Patient & Activist

Ken Getz, MBA
Director of Sponsored Research / Founder, Tufts CSDD / CISCRP

Jean McCoy
SVP, Strategy and Innovation, Health Advocacy Strategies

T.J. Sharpe
Melanoma Survivor, Advocate and Cancer Blogger

Durhane Wong-Rieger, PhD
President and CEO / Founder and Head, Canadian Organization for Rare Disorders / Consumer Advocate Network

Partnering with Patient Organizations for Advancing Cures

Lori Abrams
Director, Diversity and Patient Engagement, Bristol-Myers Squibb

Stephanie Christopher
Program Manager, Patient Centered Benefit-Risk, Medical Device Innovation Consortium

Lauren McLaughlin
Associate Director, Research Partnerships, The Michael J Fox Foundation for Parkinson’s Research

Suzanne Schrandt, JD
Director, Patient Engagement, Arthritis Foundation 

Nirmala Singh
Former Patient Engagement Director, National Kidney Foundation

A Clinical Trial That’s the Right Fit: Bringing the Latest Therapies Close to Home

Sandy Smith
Senior Director, Site Services, US Oncology Research

Integrating Patient Needs Into a Shared Patient Community Beyond the Trial

Ryan Norris
Chief Technology Officer, Be the Partner 

Patient Engagement Sources & Solutions

Helen Green
Account Director, Langland

Julie Walters
Founder, Raremark

Komathi Stem, MS
Founder and CEO, MonARC Bionetworks

Day 2

Patient Input & The Regulatory Process

Richard Moscicki, MD
Deputy Center Director for Science Operations, Center for Drug Evaluation and Research (CDER), FDA

PDUFA VI: An Update on New Performance and Procedural Goal

Theresa Mullin, PhD
Director, Office of Strategic Programs, CDER, FDA

Organizational Adoption of Patient Engagement: A CDRH Case Study on How They Have Instilled an Internal Culture of Patient Engagement

Anindita Saha
Director, External Expertise and Partnerships, Center for Devices and Radiological Health (CDRH), FDA

What Patients Want: Addressing the Gap Between Clinical Care, Patient Involvement and What Patients Actually Want

Mary Stober-Murray, MBA
Associate Director, Diversity and Patient Engagement, Bristol-Myers Squibb

John Creveling
Patient and Parkinson’s Foundation Research Advocate

Kaamilah Gilyard
Patient and Advocate

Paul Graves
VP, Head, R&D Network Relationships and Strategic Communications, Takeda Pharmaceuticals 

Deb Maskens
Vice Chair, International Kidney Cancer Coalition

Michelle Vichnin, MD
Executive Director, Oncology, Office of the Chief Medical Officer, Merck

Considering Diverse Patient Needs in Clinical Trials

Kelly Franchetti, RN, CCRN, CEN
VP, Global Patient Insights and Engagement, Mapi Group

Raising Public Awareness in Clinical Research: Lessons Learned

Ken Getz, MBA
Director of Sponsored Research / Founder, Tufts CSDD / CISCRP 

Judith Ng-Cashin, MD
Chief Scientific Officer, INC

How are Patients Being Involved Earlier in the Preclinical Research Process?

Melissa Hogan, JD
Rare Disease Patient Strategist, Founder/President, Saving Case & Friends 

Douglas McCarty, PhD
Principal Investigator, Center for Gene Therapy / Associate Professor, Department of Pediatrics, The Research Institute at Nationwide Children’s Hospital / The Ohio State University College of Medicine

Involving Patients in Clinical Trial Design for Targeted Evidence Creation: An Inspire Case Study

Jeff Terkowitz
Director, Product Management, Inspire

Including the Patient Voice in Mobile and Wearable Tech Development for Clinical Trials: A Case Study

Daisy Daeschler
Research Partnerships Officer, The Michael J Fox Foundation for Parkinson’s Research

Gary Ostroff, PhD
Research Professor in Molecular Medicine, UMass Medical School